Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation

Oncogene

Volumn 28, Issue 39, 2009, Pages 3477-3486

  Novosyadlyy, R ^a   Vijayakumar, A ^a   Lann, D ^a   Fierz, Y ^a   Kurshan, N ^a   Leroith, D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Crosstalk; IGF I receptor; Insulin receptor; Oncogenes; Polyoma virus middle T oncogene

Indexed keywords

INSULIN; INSULIN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; VIRUS MIDDLE T ANTIGEN;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; INSULIN; MAMMARY NEOPLASMS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN;

MUS; POLYOMAVIRUS;

EID: 70349684824     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.209     Document Type: Article

References (35)

1. Arbet-Engels C, Tartare-Deckert S, Eckhart W. (1999). C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor. J Biol Chem 274: 5422-5428.
2. Bartucci M, Morelli C, Mauro L, Ando S, Surmacz E. (2001). Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 61: 6747-6754.
3. Baserga R. (1999). The IGF-I receptor in cancer research. Exp Cell Res 253: 1-6.
4. Belore A, Frasca F. (2008). IGF and insulin receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13: 381-406.
5. Catrina SB, Lewitt M, Massambu C, Dricu A, Grunler J, Axelson M et al. (2005). Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival. Br J Cancer 92: 1467-1474.
6. Clemmons DR. (2007). Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 6: 821-833.
7. Dilworth SM. (2002). Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat Rev Cancer 2: 951-956.
8. DiMaio D, Lai CC, Klein O. (1998). Virocrine transformation: the intersection between viral transforming proteins and cellular signal transduction pathways. Annu Rev Microbiol 52: 397-421.
9. Feng H, Shuda M, Chang Y, Moore PS. (2008). Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319: 1096-1100.
10. Foulongne V, Kluger N, Dereure O, Brieu N, Guillot B, Segondy M. (2008). Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis 14: 1491-1493.
11. Frittitta L, Vigneri R, Stampfer MR, Goldfine ID. (1995). Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand-dependent transformed phenotype. J Cell Biochem 57: 666-669.
12. Giorgino F, Bel.ore A, Milazzo G, Costantino A, Maddux B, Whittaker J et al. (1991). Overexpression of insulin receptors in .broblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol 5: 452-459.
13. Gross L. (1951). 'Spontaneous' leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos. Proc Soc Exp Biol Med 76: 27-32.
14. Gross L. (1953). A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med 83: 414-421.
15. Guy CT, Cardiff RD, Muller WJ. (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961.
16. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. (1994). Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 8: 23-32.
17. Hynes NE, Lane HA. (2005). ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341-354.
18. Javier RT, Butel JS. (2008). The history of tumor virology. Cancer Res 68: 7693-7706.
19. Kassem A, Schop.in A, Diaz C, Weyers W, Stickeler E, Werner M et al. (2008). Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identi.cation of a unique deletion in the VP1 gene. Cancer Res 68: 5009-5013.
20. Lebrun P, Mothe-Satney I, Delahaye L, Van OE, Baron V. (1998). Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125(FAK) and pp60(src). J Biol Chem 273: 32244-32253.
21. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT. (1995). Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143-163.
22. Lieskovska J, Ling Y, Badley-Clarke J, Clemmons DR. (2006). The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J Biol Chem 281: 25041-25053.
23. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ et al. (2003). Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163: 2113-2126.
24. Morris JD, Eddleston AL, Crook T. (1995). Viral infection and cancer. Lancet 346: 754-758.
25. Ono M, Kuwano M, Kung HF. (1991). Malignant transformation of mouse BALB/3T3 cells by polyoma middle T antigen requires epidermal growth factor receptor expression. Cell Growth Differ 2: 317-322.
26. Pisani P. (2008). Hyper-insulinaemia and cancer, metaanalyses of epidemiological studies. Arch Physiol Biochem 114: 63-70.
27. Pollak M. (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8: 915-928.
28. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. (2004). Insulin-like growth factor (IGF)-I, IGF binding protein- 3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346-1353.
29. Rose PP, Carroll JM, Carroll PA, DeFilippis VR, Lagunoff M, Moses AV et al. (2007). The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma. Oncogene 26: 1995-2005.
30. Segawa K, Ito Y. (1983). Enhancement of polyoma virus middle T antigen tyrosine phosphorylation by epidermal growth factor. Nature 304: 742-744.
31. Shepard CR, Kassis J, Whaley DL, Kim HG, Wells A. (2007). PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene 26: 3020-3026.
32. Soeda E, Maruyama T, Arrand JR, Grif.n BE. (1980). Hostdependent evolution of three papova viruses. Nature 285: 165-167.
33. WhiteMK, Khalili K. (2004). Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 324: 1-16.
34. Yakar S, LeRoith D, Brodt P. (2005). The role of the growth hormone/ insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev 16: 407-420.
35. zur Hausen H. (2008). Novel human polyomaviruses-re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123: 247-250.